Ignite Creation Date:
2025-12-25 @ 12:58 AM
Ignite Modification Date:
2025-12-25 @ 11:12 PM
Study NCT ID:
NCT01155193
Status:
COMPLETED
Last Update Posted:
2018-10-29
First Post:
2010-03-02
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Prospective Study for the Use of Palivizumab (Synagis®) in High-risk Children in Germany
Sponsor:
AbbVie (prior sponsor, Abbott)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2016-07-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-07-31
Completion Date Type:
ACTUAL
First Submit Date:
2010-03-02
First Submit QC Date:
None
Study First Post Date:
2010-07-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-07-12
Results First Submit QC Date:
None
Results First Post Date:
2018-10-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-02-05
Last Update Post Date:
2018-10-29
Last Update Post Date Type:
ACTUAL